• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚焦于病理相关性和疾病复发的年轻乳腺癌(YABC)的影像学特征。

Imaging characteristics of young age breast cancer (YABC) focusing on pathologic correlation and disease recurrence.

机构信息

Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.

Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Sci Rep. 2021 Oct 12;11(1):20205. doi: 10.1038/s41598-021-99600-6.

DOI:10.1038/s41598-021-99600-6
PMID:34642389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8511101/
Abstract

The purpose of this study is to investigate imaging characteristics of young age breast cancer (YABC) focusing on correlation with pathologic factors and association with disease recurrence. From January 2017 to December 2019, patients under 40 years old who were diagnosed as breast cancer were enrolled in this study. Morphologic analysis of tumor and multiple quantitative parameters were obtained from pre-treatment dynamic contrast enhanced breast magnetic resonance imaging (DCE-MRI). Tumor-stroma ratio (TSR), microvessel density (MVD) and endothelial Notch 1 (EC Notch 1) were investigated for correlation with imaging parameters. In addition, recurrence associated factors were assessed using both clinico-pathologic factors and imaging parameters. A total of 53 patients were enrolled. Several imaging parameters derived from apparent diffusion coefficient (ADC) histogram showed negative correlation with TSR; and there was negative correlation between MVD and Ve in perfusion analysis. There were nine cases of recurrences with median interval of 16 months. Triple negative subtype and low CD34 MVD positivity in Notch 1 hotspots showed significant association with tumor recurrence. Texture parameters reflecting tumor sphericity and homogeneity were also associated with disease recurrence. In conclusion, several quantitative MRI parameters can be used as imaging biomarkers for tumor microenvironment and can predict disease recurrence in YABC.

摘要

本研究旨在探讨年轻乳腺癌(YABC)的影像学特征,重点关注与病理因素的相关性及与疾病复发的关系。 2017 年 1 月至 2019 年 12 月,纳入了年龄小于 40 岁的乳腺癌患者。从术前动态对比增强乳腺磁共振成像(DCE-MRI)中获取肿瘤形态学分析和多个定量参数。研究肿瘤-间质比(TSR)、微血管密度(MVD)和内皮 Notch 1(EC Notch 1)与影像学参数的相关性。此外,还使用临床病理因素和影像学参数评估与复发相关的因素。共纳入 53 例患者。来自表观扩散系数(ADC)直方图的几个影像学参数与 TSR 呈负相关;灌注分析中 MVD 与 Ve 呈负相关。有 9 例复发,中位间隔为 16 个月。三阴性亚型和 Notch 1 热点中 CD34 MVD 阳性率低与肿瘤复发显著相关。反映肿瘤球形度和均匀性的纹理参数也与疾病复发相关。总之,几个定量 MRI 参数可用作肿瘤微环境的影像学标志物,并可预测 YABC 的疾病复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/bf0ffeeffccb/41598_2021_99600_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/77078780061c/41598_2021_99600_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/0e4e230f7072/41598_2021_99600_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/488f9fb66a74/41598_2021_99600_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/bf0ffeeffccb/41598_2021_99600_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/77078780061c/41598_2021_99600_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/0e4e230f7072/41598_2021_99600_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/488f9fb66a74/41598_2021_99600_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f985/8511101/bf0ffeeffccb/41598_2021_99600_Fig4_HTML.jpg

相似文献

1
Imaging characteristics of young age breast cancer (YABC) focusing on pathologic correlation and disease recurrence.聚焦于病理相关性和疾病复发的年轻乳腺癌(YABC)的影像学特征。
Sci Rep. 2021 Oct 12;11(1):20205. doi: 10.1038/s41598-021-99600-6.
2
Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.动态对比增强乳腺磁共振成像用于预测乳腺癌的早期和晚期复发
Medicine (Baltimore). 2016 Nov;95(48):e5330. doi: 10.1097/MD.0000000000005330.
3
Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters.基于定量和定性磁共振成像(MRI)参数的乳腺癌复发预后因素研究。
Sci Rep. 2020 May 5;10(1):7598. doi: 10.1038/s41598-020-64564-6.
4
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.直肠癌患者动态对比增强磁共振成像灌注参数:与微血管密度和血管内皮生长因子表达的相关性。
Korean J Radiol. 2013 Nov-Dec;14(6):878-85. doi: 10.3348/kjr.2013.14.6.878. Epub 2013 Nov 5.
5
Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.动态对比增强磁共振成像参数作为人类乳腺癌血管生成和增殖的成像标志物
Med Sci Monit. 2015 Feb 1;21:376-82. doi: 10.12659/MSM.892534.
6
Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer.动态对比增强磁共振成像中的灌注参数与扩散加权磁共振成像中的表观扩散系数值:与乳腺癌预后因素的关联
Acad Radiol. 2016 Apr;23(4):446-56. doi: 10.1016/j.acra.2015.12.011. Epub 2016 Feb 3.
7
Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence.术前乳腺动态对比增强磁共振成像(DCE-MRI)扫描中乳腺癌异质性的影像学表型预测 10 年复发。
Clin Cancer Res. 2020 Feb 15;26(4):862-869. doi: 10.1158/1078-0432.CCR-18-4067. Epub 2019 Nov 15.
8
Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.雌激素受体阳性、HER2 阴性、淋巴结阴性乳腺癌的弥散加权 MRI:肿瘤内异质性与复发风险的关系。
Eur Radiol. 2020 Jan;30(1):66-76. doi: 10.1007/s00330-019-06383-6. Epub 2019 Aug 5.
9
Whole solid tumor volume histogram parameters for predicting the recurrence in patients with epithelial ovarian carcinoma: a feasibility study on quantitative DCE-MRI.预测上皮性卵巢癌患者复发的全实体瘤体积直方图参数:定量DCE-MRI的可行性研究
Acta Radiol. 2020 Sep;61(9):1266-1276. doi: 10.1177/0284185119898654. Epub 2020 Jan 19.
10
Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.应用扩散峰度成像和定量动态对比增强磁共振成像鉴别乳腺肿瘤。
J Magn Reson Imaging. 2018 Nov;48(5):1358-1366. doi: 10.1002/jmri.26059. Epub 2018 May 2.

引用本文的文献

1
Prognosis of Breast Cancer in Women in Their 20s: Clinical and Radiological Insights.20多岁女性乳腺癌的预后:临床与影像学见解
Diagnostics (Basel). 2025 Aug 19;15(16):2072. doi: 10.3390/diagnostics15162072.
2
Ready the treasure at our feet, MRI feature analysis in young women with breast cancer.准备好我们手头的资料,年轻女性乳腺癌的MRI特征分析。
Eur Radiol. 2024 Nov;34(11):7090-7091. doi: 10.1007/s00330-024-10840-2. Epub 2024 Jun 19.
3
A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.

本文引用的文献

1
Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters.基于定量和定性磁共振成像(MRI)参数的乳腺癌复发预后因素研究。
Sci Rep. 2020 May 5;10(1):7598. doi: 10.1038/s41598-020-64564-6.
2
Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer.肿瘤微血管内皮细胞中的Notch1和肿瘤miR-34a作为局部晚期三阴性乳腺癌的预后标志物
J Breast Cancer. 2019 Dec;22(4):562-578. doi: 10.4048/jbc.2019.22.e56.
3
Imaging Findings and Clinicopathological Correlation of Breast Cancer in Women under 40 Years Old.
基于 MRI 和临床病理特征的预测模型,用于预测接受术前治疗的年轻女性乳腺癌的复发情况。
Eur Radiol. 2024 Nov;34(11):7092-7103. doi: 10.1007/s00330-024-10805-5. Epub 2024 May 24.
4
Radiomics Nomogram: Prediction of 2-Year Disease-Free Survival in Young Age Breast Cancer.影像组学列线图:预测年轻乳腺癌患者的2年无病生存率
Cancers (Basel). 2022 Sep 14;14(18):4461. doi: 10.3390/cancers14184461.
40岁以下女性乳腺癌的影像学表现与临床病理相关性
Eur J Breast Health. 2019 Jul 1;15(3):147-152. doi: 10.5152/ejbh.2019.4606. eCollection 2019 Jul.
4
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.瑞博西利联合内分泌治疗乳腺癌的总生存。
N Engl J Med. 2019 Jul 25;381(4):307-316. doi: 10.1056/NEJMoa1903765. Epub 2019 Jun 4.
5
Insights Into Breast Cancer in the East vs the West: A Review.东西方乳腺癌研究洞察:综述
JAMA Oncol. 2019 Oct 1;5(10):1489-1496. doi: 10.1001/jamaoncol.2019.0620.
6
Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival.扩散加权成像在浸润性乳腺癌中的应用:与远处无转移生存的关系。
Radiology. 2019 May;291(2):300-307. doi: 10.1148/radiol.2019181706. Epub 2019 Mar 12.
7
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?乳腺癌发病年龄早是否是亚洲乳腺癌的一个独特特征?
Breast Cancer Res Treat. 2019 Jan;173(1):189-199. doi: 10.1007/s10549-018-4947-z. Epub 2018 Sep 20.
8
Prediction of Chemoresistance in Women Undergoing Neo-Adjuvant Chemotherapy for Locally Advanced Breast Cancer: Volumetric Analysis of First-Order Textural Features Extracted from Multiparametric MRI.局部晚期乳腺癌新辅助化疗女性的化疗耐药预测:多参数 MRI 提取的一阶纹理特征的容积分析。
Contrast Media Mol Imaging. 2018 May 3;2018:8329041. doi: 10.1155/2018/8329041. eCollection 2018.
9
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.来曲唑联合内分泌治疗激素受体阳性、晚期乳腺癌的绝经前妇女(MONALEESA-7):一项随机 3 期临床试验。
Lancet Oncol. 2018 Jul;19(7):904-915. doi: 10.1016/S1470-2045(18)30292-4. Epub 2018 May 24.
10
Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.利用 F-18 FDG PET/CT 和弥散加权磁共振成像肿瘤内异质性的纹理特征预测局部晚期乳腺癌新辅助化疗反应和无进展生存期。
Breast J. 2019 May;25(3):373-380. doi: 10.1111/tbj.13032. Epub 2018 Mar 30.